Cardiol Therapeutics Meets MAVERIC Enrollment Goal and Expands Trial for CardiolRx™ Efficacy Study #Canada #Toronto #Cardiol_Therapeutics #MAVERIC_trial #CardiolRx™
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialCardiol Therapeutics Obtains Over $7 Million from Warrant Exercise to Support Innovative Heart Treatment Trials #Canada #Toronto #Cardiol_Therapeutics #CardiolRx #MAVERIC_trial